Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C031903 |
1-UFT protocol |
MRE11A protein results in decreased susceptibility to 1-UFT protocol | decreases response to substance | 16734730
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of MRE11A mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of MRE11A mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of MRE11A mRNA | increases expression | 18648102
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of MRE11A mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MRE11A mRNA | affects expression | 16483693
|
C110904 |
capecitabine |
MRE11A protein results in decreased susceptibility to capecitabine | decreases response to substance | 16734730
|
C099555 |
CD 437 |
CD 437 results in decreased expression of MRE11A protein | decreases expression | 15059897
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MRE11A mRNA | decreases expression | 20106945
|
C014347 |
decitabine |
decitabine affects the localization of MRE11A protein modified form | affects localization | 17991895
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of MRE11A mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of MRE11A protein | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MRE11A mRNA] | decreases reaction|increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MRE11A protein] | decreases reaction|increases expression | 17854601
|
C025034 |
doxifluridine |
MRE11A protein results in decreased susceptibility to doxifluridine | decreases response to substance | 16734730
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of MRE11A mRNA | decreases expression | 12057914
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MRE11A mRNA | increases expression | 17950772 18301758
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of MRE11A mRNA] | increases expression|increases reaction | 17950772
|
D012402 |
Rotenone |
Rotenone results in increased expression of MRE11A mRNA | increases expression | 18191903
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
9.15 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
9.15 | 18653653 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.72 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.72 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.26 | 17162532 17620307 18056438 19061943 16434500 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.26 | 16434500 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.91 | 10982225 |
OMIM:604391 |
ATAXIA-TELANGIECTASIA-LIKE DISORDER |
marker/mechanism |
|
| |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.08 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.17 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
capecitabine |
2.15 | 12972520 18473752 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.15 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.15 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.91 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.91 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.91 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.91 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
8.91 | 20935162 16878318 17428255 16540662 17761372 19107877 16328049 20007298 20514400 19919837 17173139 18665156 17055752 21159647 16935385 16681979 11831363 18785209 3084413 3581430 20214788 17162532 19539802 10737359 16569478 18971187 16288022 19394651 19052882 18788625 18393292 19519916 17138121 19383236 19171122 16779866 19208518 18978308 17978847 20432363 20524982 20101231 20727157 20084675 18210153 16698587 19701751 19335982 18506893 19418558 16502159 18494052 10672840 18056438 16830150 19822196 16807293 20512989 18691550 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.69 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.60 | 19215824 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.60 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
16.17 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
16.17 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
16.17 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
16.17 | 17174075 2727394 7505956 21159647 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.71 | 19052882 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
13.50 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.50 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.50 | 19176532 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.34 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
capecitabine |
3.12 | 18473752 18448328 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
3.12 | 18981723 |
MESH:D003329 |
Coronary Vasospasm |
|
capecitabine |
5.84 | 17465463 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.04 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.04 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.84 | 14531868 12868966 2524372 11298694 11906362 18759878 8156756 8970840 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.44 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.52 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.20 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
12.10 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.10 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
12.10 | 18289764 7440962 9653073 6482804 18692083 9328219 8291058 11289319 18648102 1440618 9022650 6679447 16192314 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.10 | 11529661 16227642 19370779 16109766 19923254 10915739 14550746 11287661 11421492 11461765 18713872 16781746 17562736 14725611 11739529 12958197 11743745 19739265 12594235 18071297 12540782 19085960 15619225 12705907 2444490 11834606 16393943 14986274 10663392 16081117 17522070 16177239 10774834 17906064 19420014 19416960 12153990 15968718 16485898 12392966 19164858 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
12.10 | 19107877 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.16 | 19426721 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.51 | 12083418 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.18 | 19294695 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.45 | 15821434 17637181 15328337 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.18 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.11 | 3581430 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.22 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
13.22 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.22 | 19236843 20131406 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.04 | 11852909 9205823 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.08 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.18 | 12639820 12168785 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.74 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.07 | 7505956 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.50 | 19215824 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.55 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.41 | 16366002 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.55 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.04 | 16221962 19176532 18467677 19772884 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.72 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.21 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.98 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.11 | 10903974 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.22 | 17581917 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.32 | 18785209 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
5.32 | 12878042 9205823 17237260 17963957 17255318 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.65 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.66 | 17255318 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.08 | 8074119 9022650 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.85 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.85 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
17.94 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
17.94 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
17.94 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
17.94 | 12371664 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.08 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.03 | 18454857 17236224 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.38 | 19387464 17679729 18460780 19010910 18704418 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.52 | 18055864 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.75 | 15821434 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.84 | 18522880 19638242 20032147 18665156 18407596 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.21 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
2.52 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.52 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.93 | 19460945 16610002 12969438 16611625 19014921 11587558 12587719 19784758 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.93 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.26 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.45 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
7.45 | 19090486 18644402 2422723 19638242 20434301 18977376 16942905 12771043 21047994 20101389 19642983 19254457 19850985 18648771 21167192 20452335 21071580 19812893 2862719 19294768 20118626 15175105 19551842 12112319 20405173 19690152 19073162 19426721 15885732 18754104 20501860 20137499 20492335 21278145 10737359 19499222 19427195 9163691 20583210 19256749 19833225 18978307 19996281 19255062 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.45 | 20007298 16377806 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.94 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
9.94 | 598648 6587162 1399818 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
9.94 | 3124819 18775883 2563599 18079962 19004024 18544905 17942915 18164116 19009564 18253720 18308698 19539802 16842330 16267830 9362446 21159647 17854601 18282651 17174075 18093689 19126423 19519916 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.05 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.76 | 6695378 21163286 20512841 20970405 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.44 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.25 | 16505122 17785578 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.61 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.36 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.55 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.40 | 19157545 16882708 19010910 18608210 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.15 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.97 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.52 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.52 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.74 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
capecitabine |
9.74 | 12972520 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
9.74 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
capecitabine |
8.55 | 16374040 |
MESH:D009369 |
Neoplasms |
|
decitabine |
8.55 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.55 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 19348381 18481113 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.90 | 15790535 17356569 18619942 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.93 | 6679447 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.26 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.26 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.18 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
15.23 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
15.23 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
15.23 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.08 | 3988306 |
MESH:D010051 |
Ovarian Neoplasms |
|
CD 437 |
5.35 | 17474084 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
5.35 | 19331143 19259094 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.41 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.39 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.39 | 16540662 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.52 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
2.99 | 16412576 19232380 16140633 18619942 18191903 11535288 19114014 11445065 15451049 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
4.10 | 15574749 15927086 18197244 15795934 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.53 | 6228378 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.60 | 11605937 12224865 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.03 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.03 | 2563599 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.77 | 17616702 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.40 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.75 | 10835634 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.39 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.43 | 19155313 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.93 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.93 | 18551238 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.54 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.54 | 18456281 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.19 | 15821434 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.12 | 6582329 1399818 6587162 3712494 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
12.12 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
12.12 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
15.94 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
15.94 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.94 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
CD 437 |
15.94 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
15.94 | 17616700 19087683 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.16 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.16 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.01 | 10982225 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.98 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |